Galactomannan Antigenemia and Antigenuria in Aspergillosis: Studies in Patients and Experimentally Infected Rabbits
B. Dupont(Délégation Paris 5), John E. Bennett(National Institute of Allergy and Infectious Diseases), Marcel Huber(Johannes Kepler University of Linz), Sang‐Jae Kim(Jeju National University)
Cited by 145
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Practice Guidelines for Diseases Caused by Aspergillus
|Clinical Infectious Diseases|2000|797